PureATP (Pure Adenosine 5'-Triphosphate Disodium)

Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

PureATP is a NON-PROPRIETARY GENERIC FORM of adenosine 5'-triphosphate disodium used as a sports performance ingredient — distinguished from PEAK ATP (the patented, clinically-validated form by TSI Group) by lacking a documented patent or specific clinical research base. Found in some pre-workout and performance formulations under the 'PureATP' designation. Used for: athletic performance, energy support, blood flow — though clinical evidence is largely extrapolated from PEAK ATP research.

Studied Dose 400 mg/day disodium ATP (extrapolated from PEAK ATP research; PureATP-specific studies limited)
Active Compound Adenosine 5'-triphosphate disodium (generic / non-proprietary)

Benefits

Athletic Performance (Extrapolated Evidence)

PureATP delivers same active molecule (disodium ATP) as PEAK ATP — performance effects theoretically similar, though specific PureATP RCTs are limited compared to PEAK ATP's documented evidence base.

Energy Support

ATP is the universal cellular energy currency; supplementation theoretically supports energy demands.

Blood Flow / Pump

Same mechanism as other ATP forms — vasodilation via endothelial purinergic receptor signaling.

Lower-Cost Alternative to PEAK ATP

Generic disodium ATP forms typically cost less than patented PEAK ATP — relevant for cost-conscious formulations though clinical reproducibility is the trade-off.

Same Active Molecule

PureATP and PEAK ATP both deliver adenosine 5'-triphosphate disodium; chemical structure is identical.

Mechanism of action

1

Same Active Molecule as PEAK ATP

PureATP is chemically identical to PEAK ATP at the molecular level — both are adenosine 5'-triphosphate disodium; theoretical mechanism of action identical.

2

Generic vs Patented Distinction

Difference between PureATP and PEAK ATP lies primarily in: (1) absence of patent protection, (2) lack of specific manufacturing standardization documentation, (3) limited or no specific clinical trial evidence, (4) varied source manufacturing quality.

3

Bioavailability Considerations

Same oral bioavailability challenges as other ATP forms — rapid GI breakdown to metabolites; effects via downstream signaling.

4

Quality and Consistency Variables

Without proprietary manufacturing process, batch-to-batch consistency and purity may vary more than patented forms; this is a key consumer consideration.

Clinical trials

1
PureATP-Specific Clinical Studies — Limited

PureATP itself does not have a documented dedicated clinical trial portfolio; performance claims are typically extrapolated from PEAK ATP research.

Limited specific PureATP study population.

Limited PureATP-specific clinical evidence; effects extrapolated from PEAK ATP research on the same molecule.

2
PEAK ATP Research as Reference
PubMed

Wilson 2013, Jager 2014, and other PEAK ATP studies provide the underlying mechanism evidence for disodium ATP supplementation generally.

Various populations across PEAK ATP studies.

Established performance and blood flow evidence for disodium ATP; PureATP claims rely on this evidence base for the underlying molecule.

About this ingredient

About the active ingredient

PUREATP is a NON-PROPRIETARY DESIGNATION for ADENOSINE 5'-TRIPHOSPHATE DISODIUM used as a sports performance supplement ingredient. POSITIONING vs PEAK ATP: PureATP and PEAK ATP both deliver the same active molecule (disodium ATP) but differ significantly in: (1) PEAK ATP is PATENTED proprietary form by TSI Group; PureATP is generic non-proprietary; (2) PEAK ATP has 10+ peer-reviewed clinical trials; PureATP-specific evidence is limited; (3) PEAK ATP has documented manufacturing standardization; PureATP quality varies by supplier; (4) PEAK ATP costs more; PureATP positioned as cost-effective alternative; (5) Marketing claims for PureATP typically reference PEAK ATP research as evidence basis.

KEY CONSIDERATIONS: (1) SAME ACTIVE MOLECULE — chemically identical; theoretical mechanism identical; (2) CLINICAL EVIDENCE GAP — most disodium ATP clinical evidence is specifically on PEAK ATP; PureATP-specific RCTs limited; (3) QUALITY VARIABILITY — non-proprietary form quality depends on individual supplier manufacturing; verify quality testing; (4) DOSE — 400 mg/day extrapolated from PEAK ATP research as standard reference dose. EVIDENCE-BASED USES (extrapolated): (1) Athletic performance; (2) Blood flow; (3) Energy support; (4) Muscle recovery.

CRITICAL CAUTIONS: (1) BRAND CHOICE MATTERS — for clinically-validated effects, PEAK ATP has stronger evidence base; PureATP relies on extrapolation from same molecule; (2) FOR COST-CONSCIOUS FORMULATIONS — PureATP may be reasonable but evidence reproducibility uncertain; (3) PUREATP vs PEAK ATP CONSUMER GUIDANCE — for highest evidence-backed reliability, PEAK ATP preferred; for cost-effective options accepting some clinical uncertainty, PureATP may suffice; verify supplier quality; (4) SAME SAFETY PROFILE generally as PEAK ATP at appropriate doses; (5) DRUG INTERACTIONS same as generic ATP; (6) PREGNANCY/LACTATION — AVOID concentrated supplementation; (7) FOR COMPREHENSIVE EXERCISE PERFORMANCE — training, nutrition, sleep, recovery foundational; ATP supplements (PEAK ATP or PureATP) adjunct; (8) NAMING TRANSPARENCY — many products marketed as 'pure ATP' or PureATP variants actually contain PEAK ATP as the underlying ingredient with the brand obscured; verify product label; (9) GENERIC vs BRANDED INGREDIENT debate — applies broadly across supplement industry; clinical evidence base typically favors branded forms but generic forms can be valid for budget-conscious applications when quality verified.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress (rare).
Allergic reactions rare.
Sodium content from disodium ATP (relevant for sodium-restricted diets at high doses).
Quality/purity variability in non-proprietary forms — verify supplier.

Important Drug interactions

Same as generic ATP — see Adenosine 5'-Triphosphate entry.
ANTICOAGULANTS / ANTIPLATELETS — theoretical interactions.
ANTIHYPERTENSIVES — modest theoretical additive effects.
Caffeine — theoretical interactions (caffeine is adenosine receptor antagonist).
Pregnancy — AVOID concentrated supplementation.
Lactation — limited supplementation data.

Frequently asked questions about PureATP (Pure Adenosine 5'-Triphosphate Disodium)

What is the recommended dosage of PureATP (Pure Adenosine 5'-Triphosphate Disodium)?

The clinically studied dose for PureATP (Pure Adenosine 5'-Triphosphate Disodium) is 400 mg/day disodium ATP (extrapolated from PEAK ATP research; PureATP-specific studies limited). Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is PureATP (Pure Adenosine 5'-Triphosphate Disodium) used for?

PureATP (Pure Adenosine 5'-Triphosphate Disodium) is studied for athletic performance (extrapolated evidence), energy support, blood flow / pump. PureATP delivers same active molecule (disodium ATP) as PEAK ATP — performance effects theoretically similar, though specific PureATP RCTs are limited compared to PEAK ATP's documented evidence base.

Are there side effects from taking PureATP (Pure Adenosine 5'-Triphosphate Disodium)?

Reported potential side effects may include: Generally well-tolerated. Mild GI distress (rare). Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does PureATP (Pure Adenosine 5'-Triphosphate Disodium) interact with medications?

Known drug interactions may include: Same as generic ATP — see Adenosine 5'-Triphosphate entry. ANTICOAGULANTS / ANTIPLATELETS — theoretical interactions. Consult a pharmacist or healthcare provider if you take prescription medications.

Is PureATP (Pure Adenosine 5'-Triphosphate Disodium) good for athletic performance?

Yes, PureATP (Pure Adenosine 5'-Triphosphate Disodium) is researched for Athletic Performance support. PureATP delivers same active molecule (disodium ATP) as PEAK ATP — performance effects theoretically similar, though specific PureATP RCTs are limited compared to PEAK ATP's documented evidence base.